These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


345 related items for PubMed ID: 21885951

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polycythemia vera and mesenteric arterial thrombosis. A disease association resulting from decreased platelet sensitivity to aspirin.
    Myers TJ, Steinberg WM, Rickles FR.
    Arch Intern Med; 1979 Jun; 139(6):695-8. PubMed ID: 443976
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis.
    Gumina RJ, Foley DA, Tefferi A, Rooke TW, Shields RC.
    Angiology; 2002 Jun; 53(5):587-91. PubMed ID: 12365868
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Erythromelalgia and vascular complications in polycythemia vera.
    Michiels JJ.
    Semin Thromb Hemost; 1997 Jun; 23(5):441-54. PubMed ID: 9387203
    [Abstract] [Full Text] [Related]

  • 11. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y, Lee JO, Kim SH, Kim JW, Kim YJ, Lee KW, Lee JS, Bang SM.
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Histopathological manifestations of membranoproliferative glomerulonephritis and glomerular expression of plasmalemmal vesicle-associated protein-1 in a patient with polycythemia vera.
    Nishi Y, Namikoshi T, Sasaki T, Tokura T, Nagasu H, Nakanishi H, Kozuka Y, Kashihara N.
    Clin Nephrol; 2010 Nov; 74(5):393-8. PubMed ID: 20979949
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of low-dose aspirin in polycythemia vera.
    Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C, Barbui T, European Collaboration on Low-Dose Aspirin in Polycythemia Vera Investigators.
    N Engl J Med; 2004 Jan 08; 350(2):114-24. PubMed ID: 14711910
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera].
    Tekin M, Gökaslan S, Diker E, Aydoğdu S.
    Turk Kardiyol Dern Ars; 2008 Jan 08; 36(1):35-8. PubMed ID: 18453785
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.